AlzChem Group AG (ACT) Q2 2021 Earnings Report
CH:ACT Q2 2021 EPS Results
- Actual EPS
- CHF 0.83
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- CHF 0.65
CH:ACT Q2 2021 Revenue Results
- Actual Revenue
- CHF 198.78M
- Expected Revenue
- CHF 177.37M
- Beat/Miss
- Beat by +CHF 21.41M
- YoY Revenue Growth
- +9.16%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/05/2021
- Time
- Before Open
- Conference Call
- Thursday, August 5, 2021
CH:ACT Upcoming Earnings
AlzChem Group AG's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:ACT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | ―- | 1.53 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 1.321.24 | 1.49 | -16.77% (-0.25) | |
| Jul 30, 2026 | 2026 (Q2) | 1.531.53 | 1.45 | 5.73% (+0.08) | |
| Apr 30, 2026 | 2026 (Q1) | 1.631.63 | 1.33 | 22.92% (+0.30) | |
| Feb 27, 2026 | 2025 (Q4) | 1.531.53 | 1.38 | 11.41% (+0.16) | |
| Oct 30, 2025 | 2025 (Q3) | 1.471.49 | 1.13 | 31.97% (+0.36) | |
| Jul 30, 2025 | 2025 (Q2) | 1.451.45 | 1.3 | 11.35% (+0.15) | |
| Apr 30, 2025 | 2025 (Q1) | ―1.33 | 1.11 | 20.00% (+0.22) | |
| Feb 28, 2025 | 2024 (Q4) | 1.081.38 | 1 | 37.33% (+0.37) | |
| Nov 07, 2024 | 2024 (Q3) | 1.13- | 0.78 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed